SGLT2 Inhibitor Therapy in Cystic Fibrosis-related Diabetes
Clinical trial NCT06149793 · ACTIVE_NOT_RECRUITING
Trial details
- NCT number
- NCT06149793
- Sponsor
- University of Minnesota
- Status
- ACTIVE_NOT_RECRUITING
- Phase
- Phase 2, Phase 3
- Study type
- INTERVENTIONAL
- Start date
- 2024-01-08
- Primary completion
- 2025-06-03
- Enrollment
- 8
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.